[go: up one dir, main page]

AU2001239562A1 - Novel melanin concentrating hormone receptor - Google Patents

Novel melanin concentrating hormone receptor

Info

Publication number
AU2001239562A1
AU2001239562A1 AU2001239562A AU3956201A AU2001239562A1 AU 2001239562 A1 AU2001239562 A1 AU 2001239562A1 AU 2001239562 A AU2001239562 A AU 2001239562A AU 3956201 A AU3956201 A AU 3956201A AU 2001239562 A1 AU2001239562 A1 AU 2001239562A1
Authority
AU
Australia
Prior art keywords
hormone receptor
concentrating hormone
melanin concentrating
novel melanin
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239562A
Other languages
English (en)
Inventor
Masazumi Kamohara
Takeshi Kurama
Mitsuyuki Matsumoto
Shun-Ichiro Matsumoto
Tamaki Oda
Tetsu Saito
Youko Saito
Jun Takasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helix Research Institute
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Helix Research Institute
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helix Research Institute, Yamanouchi Pharmaceutical Co Ltd filed Critical Helix Research Institute
Publication of AU2001239562A1 publication Critical patent/AU2001239562A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001239562A 2000-03-24 2001-03-23 Novel melanin concentrating hormone receptor Abandoned AU2001239562A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-88588 2000-03-24
JP2000088588A JP2005229804A (ja) 2000-03-24 2000-03-24 新規なメラニンコンセントレーティングホルモン受容体
PCT/JP2001/002343 WO2001070975A1 (fr) 2000-03-24 2001-03-23 Nouveau recepteur d'hormone concentrant la melanine

Publications (1)

Publication Number Publication Date
AU2001239562A1 true AU2001239562A1 (en) 2001-10-03

Family

ID=18604448

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239562A Abandoned AU2001239562A1 (en) 2000-03-24 2001-03-23 Novel melanin concentrating hormone receptor

Country Status (3)

Country Link
JP (1) JP2005229804A (fr)
AU (1) AU2001239562A1 (fr)
WO (1) WO2001070975A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593108B1 (en) 1999-11-16 2003-07-15 Merck & Co., Inc. Nucleic acid molecule encoding a melanin-concentrating hormone receptor 2 polypeptide
JP4780365B2 (ja) * 2000-07-05 2011-09-28 武田薬品工業株式会社 Ｍｃｈ受容体アンタゴニスト・アゴニストのスクリーニング方法
DE60143525D1 (de) 2000-07-05 2011-01-05 Takeda Pharmaceutical Verfahren zum screenen von mhc-rezeptorantagonisten oder -agonisten
US6809104B2 (en) 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
US7208282B2 (en) 2001-05-31 2007-04-24 Merck & Co., Inc. Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor
US7141391B2 (en) 2001-11-13 2006-11-28 Neurogen Corporation Monkey and canine melanin concentrating hormone receptors
WO2003072780A1 (fr) * 2002-02-27 2003-09-04 Takeda Chemical Industries, Ltd. Nouvelles protéines, leurs adn et leur utilisation
AU2003262020A1 (en) * 2002-09-10 2004-04-30 Takeda Pharmaceutical Company Limited Human slt transgenic animal
PL376659A1 (pl) 2002-11-06 2006-01-09 Tularik Inc. Skondensowane związki heterocykliczne
KR100820095B1 (ko) 2006-12-14 2008-04-07 부경대학교 산학협력단 양식 넙치의 멜라닌 농축 호르몬 수용체

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1153932A1 (fr) * 1999-02-19 2001-11-14 Takeda Chemical Industries, Ltd. Nouvelle proteine de recepteur couplee a la proteine g et adn

Also Published As

Publication number Publication date
JP2005229804A (ja) 2005-09-02
WO2001070975A1 (fr) 2001-09-27

Similar Documents

Publication Publication Date Title
AU2001279294A1 (en) Melanin concentrating hormone receptor ligands
AU7315700A (en) Melanin concentrating hormone antagonist
AU6306100A (en) Improved passage-travelling device
AU2001231531A1 (en) Follicle stimulating hormones
AU5095000A (en) Receptor interacting protein rip3
AU2001273032A1 (en) Cytokine receptor zcytor17
AU2001272974A1 (en) Human receptors
AU5869100A (en) Melanin concentrating hormone receptor
AU2001239562A1 (en) Novel melanin concentrating hormone receptor
AU3916400A (en) Human transmembrane proteins
AU7635600A (en) Crutch device
AU2001277980A1 (en) Human cytokine receptor
AU2002239291A1 (en) G protein coupled receptors
AU5571400A (en) Walking device
AU2001223882A1 (en) Receptor
AU4352000A (en) Clasp-2 transmembrane proteins
AUPQ563400A0 (en) Novel receptor
AU2376501A (en) Synchronous rectification
AU3821800A (en) Auxiliary device for serving
AU5120000A (en) Structural device
GB9927215D0 (en) Hormone receptor expression
AU5491900A (en) Glycoprotein hormone family member
AU6550800A (en) Hepoxilin analogs
AU5545400A (en) Estrogen receptor
AU2085901A (en) Human secretin-like receptor